United States · FDA National Drug Code directory
Deferasirox
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69452-159_2f9b625f-3835-4481-e063-6394a90a4bf3
- Product NDC
- 69452-159
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- deferasirox
- Labeler
- Bionpharma Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180928
- Source listing expiry
- 20261231
Source-listed ingredients
- DEFERASIROX — 125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FOR SUSPENSION in 1 BOTTLE (69452-159-13) · 69452-159-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →